
New test to detect Alzheimer's in an early stage
14 January 2025
Zaragoza welcomes international experts at the first edition of the 'Medicine 2044' congress in Spain
15 January 2025CaixaImpulse Innovation helps transfer scientific knowledge to society and encourages the creation of products, services and companies related to life sciences. It provides support to innovative biomedical projects, helping them validate their assets and define their exploitation and valorization strategy, to bring them closer to the market.
The program is organized in 3 phases to best meet the needs of projects according to their nature and maturity:
- Phase 1 is designed to support projects that generate a preliminary demonstration of an essential hypothesis arising from scientific findings for one or more potential assets, and initiate the protection of intellectual property rights.
- Phase 2: is designed to support projects that have already identified and characterized one or more assets and require further validation and development, and that refine the prototype design through validation of intended use.
- Phase 3: is designed to support projects that have initiated regulatory submission and require advanced characterization of their assets, need to outline financial viability strategies, and/or are exploring exploitation models.
The financial aid will be distributed throughout the program, with a specific allocation that will depend on the phase (€50.000 maximum in phase 1; €150.000 maximum in phase 2; €500.000 maximum in phase 3). It is cumulative for projects that go through different phases.
Requirements
For projects:
- They must be related to the areas of life sciences and human health.
- They must have a clear innovative orientation, with relevant goals aimed at transferring assets to the market.
- They must belong to one of the following business areas: therapies, medical devices, diagnostics or digital health.
for requesting institutions:
- They must be legal entities in the public or non-profit sector based in Spain or Portugal.
- Type of entity: universities, university foundations, research and transfer centres, technology centres, hospitals, hospital foundations and non-profit institutions whose main activity is biomedical research.
- They must be owners or co-owners of the assets generated by the research.
- The same institution may submit more than one application as long as they are linked to different assets resulting from different research projects.
- Established companies are excluded from the call and may not form part of the consortiums.
For project leaders:
- Must be a natural person with higher education (university graduate, doctor or university professor).
- The project will be his/her main occupation and he/she may not be involved in more than one application as project manager.
- You may or may not be the principal investigator of the research project that generated the assets.
- You must be linked to the requesting institution and will need the express consent of said institution in order to submit the application.
Deadline: February 20, 2025.